Taiwan Liposome Company
18 clinical trials · Sponsor
◉ Watch Taiwan Liposome Company
| Record | Firm | Date |
|---|---|---|
| Phase 2/3 Study of TLC590 for Postsurgical Pain Management (NCT05161637) | Taiwan Liposome Company | 2025-04-01 |
| The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers (NCT04697654) | Taiwan Liposome Company | 2020-10-08 |
| Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain (NCT04123561) | Taiwan Liposome Company | 2019-11-26 |
| A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy (NCT03838133) | Taiwan Liposome Company | 2019-03-05 |
| A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee (NCT03754049) | Taiwan Liposome Company | 2019-01-21 |
| Ampholipad Real-World Data in Taiwan (NCT03641131) | Taiwan Liposome Company | 2018-09-09 |
| Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management (NCT03591146) | Taiwan Liposome Company | 2018-07-31 |
Track Taiwan Liposome Company automatically
Every clearance here is in the API, with alerts when new ones post.